Coherus Biosciences (CHRS) Presents JUPITER-06 Interim Data at ESMO Congress 2021 -- Slideshow

JUPITER-06: A Randomized, Double-blind, Phase 3 Study of Toripalimab versus Placebo In Combination with First-Line Chemotherapy for Treatment Naive Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) R.-H. Xu1, F. Wang1, C. Cui2, J. Yao3, Y. Zhang4, G. Wang5, J. Feng6, S. Yang7, Y. Fan8, J. Shi9, X.Zhang10, L. Shen11, Y.Shu12, C. Wang13, T. Dai14, T. Mao15, L. Chen16, Z. Guo17, B. Liu18, H. Pan19, Coherus Biosciences and Shanghai Junshi Biosciences. 1Department of Medical Oncology, Sun Yat-Sen ...